Jordi Galván

7PUBLICATIONS
26CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Panel data analysisPacific Peoples medicine and treatmentsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 01, 2026
Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at Week 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two Phase III Trials.

|Jul 31, 2025
Retrospective study of onychomycosis patients treated with ciclopirox 8% HPCH and oral antifungals applying artificial intelligence to electronic health records.

Gastón Roustan, José Luis López Estébaranz, Pablo De La Cueva

|May 30, 2024
Correction to: Burden of Topical Treatments in Psoriasis and Preferred Criteria of Choice: A Survey-Based Evaluation of Patients in Europe.

Anthony Bewley, Lauren Hiribarne, Jordi Galván

|May 26, 2024
Real-world use, perception, satisfaction, and adherence of calcipotriol and betamethasone dipropionate PAD-cream in patients with plaque psoriasis in Spain and Germany: results from a cross-sectional, online survey.

José Luis López Estebaranz, Hjalmar Kurzen, Jordi Galván

|Mar 08, 2024
Burden of Topical Treatments in Psoriasis and Preferred Criteria of Choice: A Survey-Based Evaluation of Patients in Europe.

Anthony Bewley, Lauren Hiribarne, Jordi Galván

|Sep 23, 2023
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review.

Tiago Torres, Jordi Galván, Nigel Crutchley

Pageof 2

Frequent Collaborators

3 joint publications

Anthony Bewley

2 joint publications

Andreas Pinter

2 joint publications

Morten Praestegaard

2 joint publications

José Luis López Estebaranz